De maligne kant van chronisch inflammatoir darmlijden

Translated title of the contribution: The malignant side of chronic inflammatory bowel disease

R. L. West*, W. Van De Vrie, W. R. Schouten, H. Van Dekken, E. J. Kuipers

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with chronic inflammatory bowel disease (IBD) have a higher risk of colorectal carcinoma, and present with this malignancy at a younger age than non-IBD individuals. In three patients, two men aged 20 and 36 years and one woman aged 34 years, colorectal cancer developed at a young age, following a long history of ulcerative colitis. Surveillance for colorectal cancer in IBD patients needs to be performed by regular colonoscopy with extensive biopsy sampling for the detection of dysplasia, regarded by many as predictive for colon carcinoma. Whenever a dysplasia-associated lesion or mass or a high-grade dysplasia is identified, there is a strong indication for colectomy. When low-grade dysplasia is found, the findings should be discussed with the patient and it should be decided whether the patient should resume surveillance or opt for colectomy.

Translated title of the contributionThe malignant side of chronic inflammatory bowel disease
Original languageDutch (Belgium)
Pages (from-to)2521-2524
Number of pages4
JournalNederlands Tijdschrift voor Geneeskunde
Volume146
Issue number52
Publication statusPublished - Dec 28 2002
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Fingerprint

Dive into the research topics of 'The malignant side of chronic inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this